A Multi-Center, Prospective, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Clinical Trial to Assess The Efficacy and Safety of Immune Globulinitravenous (HUMAN) FlebogammaÒ DIF in Patients With Post-Polio Syndrome

Principal Investigator: Martin Wice, MD